We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+3.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$78.1B
AUM Growth
-$11.4B
(-13%)
Cap. Flow
-$12.4B
Cap. Flow
% of AUM
-15.84%
Top 10 Holdings %
Top 10 Hldgs %
10.59%
Holding
4,705
New
851
Increased
1,272
Reduced
1,426
Closed
1,001
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$540M |
| 2 |
Applied Materials
AMAT
|
+$417M |
| 3 |
Analog Devices
ADI
|
+$307M |
| 4 |
Amer Sports
AS
|
+$295M |
| 5 |
RTX Corp
RTX
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$966M |
| 2 |
Microsoft
MSFT
|
+$724M |
| 3 |
Coherent
COHR
|
+$632M |
| 4 |
NVIDIA
NVDA
|
+$441M |
| 5 |
Biogen
BIIB
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.36% |
| 2 | Consumer Discretionary | 9.65% |
| 3 | Healthcare | 8.65% |
| 4 | Industrials | 7.85% |
| 5 | Financials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Prelude Therapeutics
PRLD
$305M
| $55.8K | ﹤0.01% |
16,329
-42,839
| -72% | -$112K |
|
3577
NET Power
NPWR
$125M
| $53.2K | ﹤0.01% |
34,091
-206,881
| -86% | -$441K |
|
|
CNTB
3578
Connect Biopharma Holdings
CNTB
$135M
| $51.8K | ﹤0.01% |
19,766
+3,263
| +20% | +$8.51K |
|
3579
Fate Therapeutics
FATE
$281M
| $51.7K | ﹤0.01% |
43,119
-1,484,867
| -97% | -$1.81M |
|
3580
Entravision Communication
EVC
$983M
| $51.6K | ﹤0.01% |
+17,373
| New | +$53.3K |
|
3581
GrowGeneration
GRWG
$82.9M
| $50.6K | ﹤0.01% |
46,021
-76,254
| -62% | -$95.1K |
|
|
FLX
3582
BingEx Ltd
FLX
$156M
| $50.6K | ﹤0.01% |
+19,079
| New | +$54.8K |
|
3583
DHI Group
DHX
$166M
| $50K | ﹤0.01% |
17,788
-17,909
| -50% | -$39.7K |
|
3584
MDxHealth
MDXH
$21.1M
| $47.8K | ﹤0.01% |
20,767
-44,211
| -68% | -$150K |
|
3585
Pyxis Oncology
PYXS
$165M
| $46.7K | ﹤0.01% |
32,006
-156,130
| -83% | -$235K |
|
3586
Identive
INVE
$64.6M
| $45.6K | ﹤0.01% |
+12,321
| New | +$41.5K |
|
3587
Anixa Biosciences
ANIX
$126M
| $44.6K | ﹤0.01% |
17,276
-13,780
| -44% | -$40.8K |
|
3588
Chegg
CHGG
$108M
| $42K | ﹤0.01% |
56,631
+12,290
| +28% | +$8.63K |
|
3589
Vera Bradley
VRA
$105M
| $41.8K | ﹤0.01% |
13,225
-12,304
| -48% | -$35K |
|
3590
Valens Semiconductor
VLN
$176M
| $41.7K | ﹤0.01% |
36,867
+8,745
| +31% | +$13.7K |
|
3591
Standard BioTools
LAB
$326M
| $41.1K | ﹤0.01% |
44,721
-98,586
| -69% | -$119K |
|
|
IMDX
3592
Insight Molecular Diagnostics
IMDX
$153M
| $40.2K | ﹤0.01% |
+12,250
| New | +$71.1K |
|
3593
TRX Gold Corp
TRX
$255M
| $37.8K | ﹤0.01% |
+25,106
| New | +$37K |
|
3594
Mercer International
MERC
$44.9M
| $30.8K | ﹤0.01% |
+21,698
| New | +$41.4K |
|
3595
CALL
Tiziana Life Sciences
TLSA
$114M
| $30.3K | ﹤0.01% |
25,900
+1,200
| +5% | +$1.7K |
|
|
OPENW
3596
Opendoor Technologies Inc Series K Warrants
OPENW
$11.2M
| $29.4K | ﹤0.01% |
48,657
+12,156
| +33% | +$10.9K |
|
|
GLDG
3597
GoldMining Inc
GLDG
$179M
| $28.2K | ﹤0.01% |
23,753
-159,220
| -87% | -$239K |
|
3598
Definitive Healthcare
DH
$72.1M
| $26.7K | ﹤0.01% |
21,709
-39,440
| -64% | -$68.6K |
|
|
LPRO
3599
Open Lending Corp
LPRO
$373M
| $26.6K | ﹤0.01% |
21,288
-8,887
| -29% | -$14.1K |
|
3600
Rackspace Technology
RXT
$1B
| $26.6K | ﹤0.01% |
+27,122
| New | +$33K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Point72 Asset Management held 4,705 positions worth $78.1B, down 13% from $89.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management withdrew a net $12.4B in Q1 2026, closing 1,001 positions and reducing 1,426 holdings. Its most notable exit was PepsiCo, an estimated $367M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Point72 Asset Management opened a new position in PPL Corp worth $216M.
- Point72 Asset Management's largest Q1 2026 buy was PPL Corp: 5,659,324 shares worth $216M.
- Point72 Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $540M increase.
- Point72 Asset Management's biggest Q1 2026 reduction was TSMC, cutting an estimated $966M.
- Point72 Asset Management fully exited PepsiCo in Q1 2026, selling an estimated $367M.
- Point72 Asset Management's ten largest holdings make up 11% of its $78.1B portfolio in Q1 2026.
- Point72 Asset Management opened 851 new positions and closed 1,001 in Q1 2026.
- Point72 Asset Management's portfolio value fell 13% quarter-over-quarter to $78.1B.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.